The Nurse Champion Model for Sickle Cell Disease Early Diagnosis and Care Access
镰状细胞病早期诊断和护理的护士冠军模型
基本信息
- 批准号:10218332
- 负责人:
- 金额:$ 17.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-15 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAfrica South of the SaharaAfricanBirthBlood VesselsCaringCharacteristicsChildChild CareChild HealthChild MortalityChronic DiseaseClientClinicalClinical PathwaysCommunitiesComprehensive Health CareConsolidated Framework for Implementation ResearchCost AnalysisCounselingCountryDevelopmentDevicesDiagnosisDiagnosticDiscipline of NursingEarly DiagnosisEducationEducational StatusEffectivenessEndemic DiseasesEquipment and supply inventoriesEthnographyEvaluationEvidence based practiceFeasibility StudiesFocus GroupsFoundationsGeographic LocationsGoalsGroup InterviewsHIVHealthHealth PersonnelHealth Services AccessibilityHealth systemHemoglobinHumanHuman ResourcesInfantInterventionInterviewLaboratoriesLeadLifeLife ExpectancyMethodsModelingMorbidity - disease rateNeonatal ScreeningNewborn InfantNursesNursing ResearchOrganOutcomePatient EducationPerformancePhasePre-Post TestsPreventionPreventive carePreventive measurePrimary Health CareProcessProviderPublic HealthResearchResourcesRuralSickle Cell AnemiaSierra LeoneSiteStandardizationSurvival RateTimeTrainingTraining ProgramsUnited States National Institutes of Healthbaseburden of illnesscare coordinationcostdesigndisease diagnosisearly screeningeffectiveness implementation studyevidence basefield studyfollow-upformative assessmentimplementation barriersimplementation costimplementation facilitatorsimplementation frameworkimplementation outcomesimplementation studyimprovedinnovationinterestlaboratory experiencemortalityneonatenovelpeerperformance testspoint of care testingprimary care settingprogramsresearch studyresponsescreeningscreening programstandard of caresupport tools
项目摘要
Abstract
Sickle cell disease (SCD) is a major contributor to child morbidity and mortality. Life expectancy of babies with
SCD varies widely depending on geographic location. In the USA, universal newborn screening (NBS) facilitates
early diagnosis and prompt linkage to care with overall survival rate in SCD children greater than 94%. In Sub-
Saharan Africa (SSA) approximately 90% of the children born annually with SCD will die before their fifth birthday,
often undiagnosed. The absence of early diagnosis through laboratory-based NBS program is a major barrier to
implementation of timely preventive measures in SSA. Emergent, novel, inexpensive, point-of-care tests
(POCTs), with analytic characteristics and field-tested performance comparable to laboratory methods offer
intriguing options for early diagnosis of SCD in primary health centers (PHCs). Our study objective is to use a
type-2 hybrid implementation-effectiveness design to assess and pilot a SCD-POCT model in one urban and
one rural PHC over 6 months in Sierra Leone where our extant SCD health systems strengthening and human
capacity building research program is housed. Our rationale is that early SCD diagnosis in neonates
demonstrably decreases morbidity and mortality rates considerably in the first 5 years of life. In this feasibility
study, the research aims include developing and assisting PHCs in implementing the model; evaluating
processes/determinants of model implementation; and evaluating the model’s effectiveness, acceptability and
effects on provider and client outcomes. Using implementation science frameworks, our research team will
iteratively engage key stakeholders to inform the development of the PHC-based SCD-POCT model. The
evidence-informed nurse champion platform will frame the implementation model and will include pre/post-test
counseling, nurse administered POCT and care coordination. Nurses will complete a comprehensive provider
training program prior to implementing the model. Three specific aims undergird our study: (1) Assess barriers
and facilitators to primary health center provision of SCD-POCT with a nurse champion model; (2) Finalize an
implementation plan for the intervention using Implementation Mapping and stakeholder input; and (3) pilot the
nurse champion model in two primary health centers and evaluate determinants and implementation costs. The
process of developing and implementing the model will be described using implementation science frameworks,
ethnographic observations, qualitative interviews and implementation mapping to identify barriers/enablers.
Nurse and client outcomes will be assessed by focus groups and in-depth interviews. Model implementation will
be assessed qualitatively and quantitatively. Acceptability, barriers, and enablers will be examined qualitatively
based on focus group and interview responses. A preliminary costing assessment will consider the nurses and
research study financial outlays. We expect our study to establish the feasibility and scalability of SCD-POCT
intervention within extant and sustainable clinical pathways in PHCs in the sub-Saharan African settings.
摘要
镰状细胞病(SCD)是儿童发病率和死亡率的主要原因。婴儿的预期寿命
SCD因地理位置而异。在美国,新生儿普遍筛查(NBS)
早期诊断和及时联系护理,SCD儿童的总生存率大于94%。在子-
撒哈拉非洲(SSA)每年出生的SCD儿童中约有90%将在五岁生日前死亡,
经常无法确诊。缺乏通过基于实验室的NBS项目进行早期诊断是一个主要障碍,
及时采取预防措施。紧急、新颖、廉价的床旁检测
(POCT),具有与实验室方法相当的分析特性和现场测试性能,
在初级卫生中心(PHCs)早期诊断SCD的有趣的选择。我们的研究目标是使用
第2类混合实施效果设计,以评估和试点一个城市的SCD-POCT模型,
在塞拉利昂的一个农村初级保健中心,我们现有的SCD卫生系统得到加强,
能力建设研究计划是住房。我们的基本原理是新生儿SCD的早期诊断
明显降低生命前5年的发病率和死亡率。在这种可行性中,
研究的目的包括发展和协助初级保健中心实施该模式;评估
模型实施的过程/决定因素;以及评估模型的有效性、可接受性和
对供应商和客户结果的影响。使用实施科学框架,我们的研究团队将
迭代地让关键利益相关者参与,为基于PHC的SCD-POCT模型的开发提供信息。的
循证护士冠军平台将制定实施模式,并将包括前/后测试
咨询、护士管理POCT和护理协调。护士将完成一个全面的提供者
在实施该模式之前,我们的研究有三个具体目标:(1)评估障碍
和促进者,以初级卫生中心提供SCD-POCT与护士冠军模式;(2)最终确定
利用实施规划和利益相关者的投入制定干预措施的实施计划;以及(3)对
护士冠军模式在两个初级卫生中心,并评估决定因素和实施成本。的
将使用实施科学框架描述开发和实施模型的过程,
民族志观察、定性访谈和执行情况摸底,以确定障碍/促进因素。
护士和客户的结果将通过焦点小组和深入访谈进行评估。模型实施将
进行定性和定量评估。可接受性、障碍和促进因素将得到定性审查
基于焦点小组和访谈的回答。初步成本评估将考虑护士和
研究经费。我们希望我们的研究能够建立SCD-POCT的可行性和可扩展性
在撒哈拉以南非洲地区的初级保健中,在现有和可持续的临床路径中进行干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cheedy Jaja其他文献
Cheedy Jaja的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cheedy Jaja', 18)}}的其他基金
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy
将镰状细胞血红蛋白病团体生殖遗传咨询的护士冠军模型纳入初级保健:一项试点实施科学研究
- 批准号:
10491753 - 财政年份:2022
- 资助金额:
$ 17.61万 - 项目类别:
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy
将镰状细胞血红蛋白病团体生殖遗传咨询的护士冠军模型纳入初级保健:一项试点实施科学研究
- 批准号:
10666605 - 财政年份:2022
- 资助金额:
$ 17.61万 - 项目类别:
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling forSickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation ScienceStudy
将镰状细胞血红蛋白病团体生殖遗传咨询的护士冠军模型纳入初级保健:一项试点实施科学研究
- 批准号:
10553408 - 财政年份:2022
- 资助金额:
$ 17.61万 - 项目类别:
The Nurse Champion Model for Sickle Cell Disease Early Diagnosis and Care Access
镰状细胞病早期诊断和护理的护士冠军模型
- 批准号:
10640838 - 财政年份:2021
- 资助金额:
$ 17.61万 - 项目类别:
The Nurse Champion Model for Sickle Cell Disease Early Diagnosis and Care Access
镰状细胞病早期诊断和护理的护士冠军模型
- 批准号:
10383727 - 财政年份:2021
- 资助金额:
$ 17.61万 - 项目类别:
Integrating Nurse Champion Model for Group Reproductive Genetic Counseling for Sickle Cell Hemoglobinopathies into Primary Care: A Pilot Implementation Science Study
将镰状细胞血红蛋白病团体生殖遗传咨询的护士冠军模型纳入初级保健:一项试点实施科学研究
- 批准号:
10292492 - 财政年份:2021
- 资助金额:
$ 17.61万 - 项目类别:
Pharmacogenetic Optimization of Analgesic Prescribing in Sickle Cell Disease
镰状细胞病镇痛处方的药物遗传学优化
- 批准号:
8534286 - 财政年份:2011
- 资助金额:
$ 17.61万 - 项目类别:
Pharmacogenetic Optimization of Analgesic Prescribing in Sickle Cell Disease
镰状细胞病镇痛处方的药物遗传学优化
- 批准号:
8321947 - 财政年份:2011
- 资助金额:
$ 17.61万 - 项目类别:
Pharmacogenetic Optimization of Analgesic Prescribing in Sickle Cell Disease
镰状细胞病镇痛处方的药物遗传学优化
- 批准号:
8190974 - 财政年份:2011
- 资助金额:
$ 17.61万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 17.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 17.61万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 17.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 17.61万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 17.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 17.61万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 17.61万 - 项目类别:
Standard Grant